Bruck H - Search Results

1

Avosentan reduces albumin excretion in diabetics with macroalbuminuria.

Wenzel RR, Littke T, Kuranoff S, Jürgens C, Bruck H, Ritz E, Philipp T, Mitchell A; SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators. Wenzel RR, et al. Among authors: bruck h. J Am Soc Nephrol. 2009 Mar;20(3):655-64. doi: 10.1681/ASN.2008050482. Epub 2009 Jan 14. J Am Soc Nephrol. 2009. PMID: 19144760 Free PMC article. Clinical Trial.

2

Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.

Wenzel RR, Rüthemann J, Bruck H, Schäfers RF, Michel MC, Philipp T. Wenzel RR, et al. Among authors: bruck h. Br J Clin Pharmacol. 2001 Aug;52(2):151-7. doi: 10.1046/j.0306-5251.2001.01422.x. Br J Clin Pharmacol. 2001. PMID: 11488771 Free PMC article. Clinical Trial.

3

Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.

Wenzel RR, Siffert W, Bruck H, Philipp T, Schäfers RF. Wenzel RR, et al. Among authors: bruck h. Pharmacogenetics. 2002 Aug;12(6):489-95. doi: 10.1097/00008571-200208000-00010. Pharmacogenetics. 2002. PMID: 12172218

4

Antihypertensive drugs and the sympathetic nervous system.

Wenzel RR, Bruck H, Noll G, Schäfers RF, Daul AE, Philipp T. Wenzel RR, et al. Among authors: bruck h. J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S43-52. doi: 10.1097/00005344-200000004-00006. J Cardiovasc Pharmacol. 2000. PMID: 11346218 Review.

5

Skin microcirculation in healthy subjects and patients with arteriosclerosis.

Wenzel RR, Bruck H, Baumgart D, Oldenburg O, Erbel R, Philipp T. Wenzel RR, et al. Among authors: bruck h. Herz. 1999 Nov;24(7):576-80. doi: 10.1007/BF03044229. Herz. 1999. PMID: 10609164 Review.

6

The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine.

Bruck H, Gössl M, Spitthöver R, Schäfers RF, Kohnle M, Philipp T, Wenzel RR. Bruck H, et al. J Hypertens. 2001 May;19(5):907-11. doi: 10.1097/00004872-200105000-00011. J Hypertens. 2001. PMID: 11393674

7

Beta 2-adrenoceptor-mediated intrinsic sympathomimetic activity of carteolol: an in vivo study.

Bruck H, Poller U, Lüssenhop H, Pönicke K, Temme T, Heusch G, Philipp T, Brodde OE. Bruck H, et al. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):361-8. doi: 10.1007/s00210-004-0988-4. Epub 2004 Oct 23. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15526107 Clinical Trial.

8

The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.

Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde OE. Bruck H, et al. J Am Coll Cardiol. 2005 Dec 6;46(11):2111-5. doi: 10.1016/j.jacc.2005.08.041. Epub 2005 Nov 4. J Am Coll Cardiol. 2005. PMID: 16325050 Free article.

9

Associations of smoking with alterations in renal hemodynamics may depend on sex--investigations in potential kidney donors.

Guberina H, Baumann M, Bruck H, Feldkamp T, Nürnberger J, Kribben A, Philipp T, Witzke O, Sotiropoulos G, Mitchell A. Guberina H, et al. Among authors: bruck h. Kidney Blood Press Res. 2013;37(6):611-21. doi: 10.1159/000355741. Epub 2013 Dec 15. Kidney Blood Press Res. 2013. PMID: 24356551 Free article.

10

Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.

Bruck H, Leineweber K, Park J, Weber M, Heusch G, Philipp T, Brodde OE. Bruck H, et al. Clin Pharmacol Ther. 2005 Sep;78(3):232-8. doi: 10.1016/j.clpt.2005.06.002. Clin Pharmacol Ther. 2005. PMID: 16153394 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page